Stock Earnings

Question 1

What are Shanghai Junshi Biosciences Co., Ltd.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Shanghai Junshi Biosciences Co., Ltd. has a total asset of $12,382, Net loss of $-875

Question 2

What are the key financial ratios for SHJBF?

Accepted Answer

Shanghai Junshi Biosciences Co., Ltd.'s Current ratio is 1.94, has a Net margin is -35.02, sales per share of $2.48.

Question 3

How is Shanghai Junshi Biosciences Co., Ltd.'s revenue broken down by segment or geography?

Accepted Answer

Shanghai Junshi Biosciences Co., Ltd. largest revenue segment is Innovative Drugs, at a revenue of 1,948,317,315 in the most earnings release.For geography, China is the primary market for Shanghai Junshi Biosciences Co., Ltd., at a revenue of 1,853,570,980.

Question 4

Is Shanghai Junshi Biosciences Co., Ltd. profitable?

Accepted Answer

no, according to the latest financial statements, Shanghai Junshi Biosciences Co., Ltd. has a net loss of $-875

Question 5

Does Shanghai Junshi Biosciences Co., Ltd. have any liabilities?

Accepted Answer

yes, Shanghai Junshi Biosciences Co., Ltd. has liability of 6,351

Question 6

How many outstanding shares for Shanghai Junshi Biosciences Co., Ltd.?

Accepted Answer

Shanghai Junshi Biosciences Co., Ltd. has a total outstanding shares of 1,026.68

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	2,498	2,498	1,948	1,502	1,453	4,024
Revenue Growth (YoY)	28%	28%	30%	3%	-64%	152%
Cost of Revenue	489	530	523	634	526	1,258
Gross Profit	2,008	1,967	1,424	868	927	2,766
Selling, General & Admin	1,544	1,432	1,347	1,337	1,178	1,272
Research & Development	1,342	1,252	1,189	1,813	2,269	1,988
Operating Expenses	2,929	2,846	2,705	3,347	3,646	3,360
Other Non Operating Income (Expenses)	-23	-23	-17	-33	-11	-36
Pretax Income	-1,023	-1,023	-1,357	-2,491	-2,677	-595
Income Tax Expense	-13	-13	22	43	-93	135
Net Income	-875	-875	-1,280	-2,283	-2,388	-720
Net Income Growth	-32%	-32%	-44%	-4%	231.99%	-56.99%
Shares Outstanding (Diluted)	1,045.28	1,005.94	985.68	984.23	918.48	890.01
Shares Change (YoY)	6%	2%	0%	7%	3%	8%
EPS (Diluted)	-0.83	-0.87	-1.29	-2.32	-2.6	-0.81
EPS Growth	-36%	-33%	-44%	-11%	221%	-60%
Free Cash Flow	-1,287	-1,287	-2,124	-2,837	-2,170	-1,506
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	80.38%	78.74%	73.1%	57.78%	63.79%	68.73%
Operating Margin	-36.82%	-35.18%	-65.7%	-165.04%	-187.06%	-14.76%
Profit Margin	-35.02%	-35.02%	-65.7%	-151.99%	-164.34%	-17.89%
Free Cash Flow Margin	-51.52%	-51.52%	-109.03%	-188.88%	-149.34%	-37.42%
EBITDA	--	-664	-1,056	-2,236	-2,487	-404
EBITDA Margin	--	-26.58%	-54.2%	-148.86%	-171.16%	-10.03%
D&A For EBITDA	--	215	224	243	231	190
EBIT	-920	-879	-1,280	-2,479	-2,718	-594
EBIT Margin	-36.82%	-35.18%	-65.7%	-165.04%	-187.06%	-14.76%
Effective Tax Rate	1.27%	1.27%	-1.62%	-1.72%	3.47%	-22.68%

Shanghai Junshi Biosciences Co., Ltd. (SHJBF) Financial

SHJBF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is SHANGHAI JUNSHI BIOSCIENCES CO ?

SHJBF Income

Follow-Up Questions